BioRad Laboratories (BIO)
(Real Time Quote from BATS)
$288.34 USD
-1.91 (-0.66%)
Updated May 24, 2024 11:32 AM ET
4-Sell of 5 4
C Value C Growth B Momentum C VGM
Price, Consensus and EPS Surprise
BIO 288.34 -1.91(-0.66%)
Will BIO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BIO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BIO
Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down
Bio-Rad Laboratories (BIO) Q1 Earnings Surpass Estimates
BIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Preview: National Vision (EYE) Q1 Earnings Expected to Decline
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
New Strong Sell Stocks for April 19th
Other News for BIO
Bio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare Conference
Spirax-Sarco trading as expected, maintains annual growth guidance
SPY ETF Update, 5/9/2024���
What's Driving Globus Medical Inc's Surprising 20% Stock Rally?
Analysts Are Bullish on These Healthcare Stocks: Bio-Rad Laboratories (BIO), Caribou Biosciences (CRBU)